<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02503449</url>
  </required_header>
  <id_info>
    <org_study_id>LYN-316</org_study_id>
    <nct_id>NCT02503449</nct_id>
  </id_info>
  <brief_title>Clinical Trial of Pulmonary Cryptococcosis in China</brief_title>
  <acronym>MCTOPCIC</acronym>
  <official_title>Multi-center Clinical Trial of Pulmonary Cryptococcosis in China</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zhixin Liang</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Chinese PLA General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Chao Yang Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ministry of Health, China</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Peking University Third Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tianjin Medical University General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>First Hospital of China Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shengjing Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Second Hospital of Jilin University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shandong Provincial Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Huadong Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Nanjing PLA General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fuzhou General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Guangzhou Institute of Respiratory Disease</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Wuhan TongJi Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Health Science Center of Xi’an Jiaotong University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Guizhou Provincial People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shenyang Military General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Second Hospital of Hebei Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Xiangya Hospital of Central South University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fujian Provincial Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fuzhou Pulmonary Hospital of Fujian</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Southwest Hospital, China</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>First Affiliated Hospital of Zhejiang University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Wenzhou Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shanghai Zhongshan Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First Affiliated Hospital of Nanchang University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Longyan City First Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Chinese PLA General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study:1.Improve the understanding of the risk factors of pulmonary
      cryptococcosis;2.Improve the awareness of pulmonary cryptococcosis clinical and imaging
      manifestations;3.Grasp pulmonary cryptococcosis patients of clinical and imaging
      manifestations in different conditions;4.Learn about antibacterial activity of antifungal
      drugs for cryptococcosis in China.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. Patients corresponding to inclusion criteria and obtaining informed consent are included
           in the research in department of respiration ward in cooperative hospitals.

        2. Relevant case report forms are created in this study.

        3. Basic information such as age,weight and height is recorded in selected cases.Clinical
           manifestations,risk factors,laboratory examination,imaging examination,etiological
           examination and histopathological examination are also recorded in selected cases by
           case report forms.In addition,antifungal treatment is recorded including name,dose,time
           of starting treatment and terminate treatment.Causes of terminate treatment and curative
           effect evaluation should be analysed.

        4. Statistical analysis.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Enrolling by invitation</last_known_status>
  <start_date>December 2014</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Month</target_duration>
  <primary_outcome>
    <measure>differences in clinical manifestations of pulmonary cryptococcosis</measure>
    <time_frame>30 days</time_frame>
    <description>Methods including laboratory examination(routine blood test),imaging examination(chest CT),scoring system(APACHE II score)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>treatment of pulmonary cryptococcosis</measure>
    <time_frame>30 days</time_frame>
    <description>Efficacy as measured by recording dose and time of therapy for antifungal agents</description>
  </secondary_outcome>
  <enrollment type="Actual">260</enrollment>
  <condition>Cryptococcosis</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      sputum,whole blood,pleural effusion,lung tissue,cerebrospinal fluid,fungus(smear
      examination,culture and identification,antigen detection,drug sensitive test)
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        1. Improve the understanding of the risk factors of pulmonary cryptococcosis.

          2. Improve the awareness of pulmonary cryptococcosis clinical and imaging manifestations.

          3. Grasp pulmonary cryptococcosis patients of clinical and imaging manifestations in
             different conditions.

          4. Learn about antibacterial activity of antifungal drugs for cryptococcosis in China.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients possess clinical or imaging manifestations of pulmonary infections,with any of the
        results(by one of following conditions) by microbiological examination or histopathologic
        examination

          1. Cryptococcal capsular polysaccharide antigen of blood or pleural effusion is positive

          2. Cryptococcus（fungus culture) is discovered by lower respiratory tract specimens

          3. Cryptococcus（pleural effusions culture) is discovered by pleural effusions collected
             under sterile condition

          4. Cryptococcus（pus culture) is discovered by pus smear out of pulmonary infections in
             disseminated infection patients

          5. Cryptococcus（blood culture) is discovered by microscopy of specimens of blood smear

          6. Cryptococcus is discovered by culturing of the pathological tissue specimens in
             aseptic condition

          7. Cryptococcal capsular budding yeast with inflammatory reaction is discovered by
             histopathological examination,cell pathology examination or microscopic examination in
             aseptic condition

        Exclusion Criteria:

          1. Patients suffer from acquired immune deficiency syndrome

          2. Patients or their legal guardians request to withdraw the clinical research
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zhixin Liang, Doctor</last_name>
    <role>Study Director</role>
    <affiliation>Chinese PLA General Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Zhen Wang</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beijing Chao Yang Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yanming Li</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ministry of Health, China</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lina Sun</last_name>
    <role>Principal Investigator</role>
    <affiliation>Peking University Third Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jie Cao</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tianjin Medical University General Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yunzhuo Chu</last_name>
    <role>Principal Investigator</role>
    <affiliation>First Hospital of China Medical University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Zhijie Zhang</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shengjing Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yufen Jin</last_name>
    <role>Principal Investigator</role>
    <affiliation>Second Hospital of Jilin University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Xiaobin Ma</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shandong Provincial Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yanping Zhu</last_name>
    <role>Principal Investigator</role>
    <affiliation>Huadong Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Xin Su</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nanjing PLA General Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Guoxiang Lai</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fuzhou General Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Feng Ye</last_name>
    <role>Principal Investigator</role>
    <affiliation>Guangzhou Institute of Respiratory Disease</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Shengdao Xiong</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wuhan TongJi Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lan Yang</last_name>
    <role>Principal Investigator</role>
    <affiliation>Health Science Center of Xi’an Jiaotong University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hong Yu</last_name>
    <role>Principal Investigator</role>
    <affiliation>Guizhou Provincial People's Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>wencheng Xue</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shenyang Military General Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yadong Yuan</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Second Hospital of Hebei Medical University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Chengping Hu</last_name>
    <role>Principal Investigator</role>
    <affiliation>Xiangya Hospital of Central South University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Baosong Xie</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fujian Provincial Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Xiaohong Chen</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fuzhou Pulmonary Hospital of Fujian</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Xiangdong Zhou</last_name>
    <role>Principal Investigator</role>
    <affiliation>Southwest Hospital, China</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Wenjiang Ma</last_name>
    <role>Principal Investigator</role>
    <affiliation>First Affiliated Hospital of Zhejiang University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yuping Li</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wenzhou Medical University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hongni Jiang</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shanghai Zhongshan Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Wei Bai</last_name>
    <role>Principal Investigator</role>
    <affiliation>The First Affiliated Hospital of Nanchang University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sucheng Zhong</last_name>
    <role>Principal Investigator</role>
    <affiliation>Longyan City First Hospital</affiliation>
  </overall_official>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 28, 2014</study_first_submitted>
  <study_first_submitted_qc>July 17, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 21, 2015</study_first_posted>
  <last_update_submitted>July 17, 2015</last_update_submitted>
  <last_update_submitted_qc>July 17, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 21, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Chinese PLA General Hospital</investigator_affiliation>
    <investigator_full_name>Zhixin Liang</investigator_full_name>
    <investigator_title>Chinese Medical Association of respiratory diseases</investigator_title>
  </responsible_party>
  <keyword>Pulmonary Cryptococcosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cryptococcosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

